New-onset diabetes after transplant (NODAT) is a condition where diabetes develops in an individual who previously was not living with diabetes, after a solid organ transplant.
It’s a common and serious complication, occurring in 2% to 53% of all solid organ transplants.
It can occur as a side effect of the medications that you need to prevent rejection of your new organ.
NODAT is associated with increased risks of infection, cardiovascular events, graft rejection, and reduced patient survival.
As with many chronic diseases, early detection, active management, and regular engagement with appropriate healthcare professionals enable people living with diabetes to achieve better health outcomes and improved quality of life.